Please assess the completion status of the following clinical trial:

Trial Title: Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with the second and subsequent attack of recurrent pericarditis,~* Age≥ 18 years,~* Informed consent.~Exclusion Criteria:~* Suspected neoplastic, tuberculous, or purulent etiology,~* Known severe liver disease and/or elevated transaminases \>1.5 times the upper limit of normality,~* serum creatinine\>2.5 mg/dl,~* Serum CK over the upper limit of normality or Known myopathy,~* Known gastrointestinal or blood disease,~* Pregnant or lactating women or women not protected by a contraception method,~* Known hypersensibility to colchicine,~* Treatment with colchicine at the enrolment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Colchicine (Type: EXPERIMENTAL): Colchicine 0.5mg BID (\>70Kg) or 0.5 once daily for 6 months
- Placebo (Type: PLACEBO_COMPARATOR): Placebo 0.5mg BID (\>70Kg) or 0.5 once daily for 6 months

Based on this trial design, predict the completion outcome and termination type (if applicable).